Takeda investors back $59 billion Shire deal, but wary of debt load
2018-12-5 03:51 pm
Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.
Read The Rest at
Thomas Cook shares climb 45 percent but bonds...
Thyssenkrupp's top shareholder appoints...
You May Also Like
Nascar Founding Family Strikes Deal to Take...
NASCAR is buying International Speedway for $2...
ICC World Cup 2019: Bangladesh aim for...
AMI investor may join group backing Jimmy...
Trump calls for trade deal passage before...
Saudi Aramco signs US LNG deal with Sempra
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version